Trust Company of Vermont’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $18M | Buy |
65,905
+2,829
| +4% | +$769K | 0.75% | 38 |
|
|
2025
Q3 | $17M | Buy |
63,076
+1,780
| +3% | +$484K | 0.74% | 41 |
|
|
2025
Q2 | $16.9M | Buy |
61,296
+400
| +0.7% | +$109K | 0.8% | 35 |
|
|
2025
Q1 | $16.2M | Buy |
60,896
+2,906
| +5% | +$717K | 0.81% | 37 |
|
|
2024
Q4 | $13.5M | Buy |
57,990
+6,266
| +12% | +$1.44M | 0.65% | 47 |
|
|
2024
Q3 | $11.4M | Buy |
51,724
+722
| +1% | +$149K | 0.57% | 53 |
|
|
2024
Q2 | $10M | Buy |
51,002
+1,250
| +3% | +$258K | 0.54% | 55 |
|
|
2024
Q1 | $10.7M | Buy |
49,752
+1,784
| +4% | +$375K | 0.6% | 53 |
|
|
2023
Q4 | $10.1M | Buy |
47,968
+137
| +0.3% | +$29.2K | 0.67% | 49 |
|
|
2023
Q3 | $9.58M | Buy |
47,831
+1,930
| +4% | +$384K | 0.65% | 50 |
|
|
2023
Q2 | $8.5M | Buy |
45,901
+3,390
| +8% | +$626K | 0.55% | 55 |
|
|
2023
Q1 | $8.14M | Buy |
42,511
+1,124
| +3% | +$203K | 0.57% | 53 |
|
|
2022
Q4 | $6.96M | Sell |
41,387
-592
| -1% | -$103K | 0.51% | 61 |
|
|
2022
Q3 | $7.44M | Buy |
41,979
+300
| +0.7% | +$59.3K | 0.59% | 48 |
|
|
2022
Q2 | $8.53M | Buy |
41,679
+80
| +0.2% | +$17K | 0.65% | 45 |
|
|
2022
Q1 | $9.89M | Sell |
41,599
-10
| -0% | -$2.35K | 0.67% | 44 |
|
|
2021
Q4 | $9.51M | Buy |
41,609
+429
| +1% | +$94.4K | 0.6% | 50 |
|
|
2021
Q3 | $7.96M | Buy |
41,180
+446
| +1% | +$90.4K | 0.57% | 58 |
|
|
2021
Q2 | $8.66M | Buy |
40,734
+1,141
| +3% | +$241K | 0.6% | 51 |
|
|
2021
Q1 | $8.09M | Buy |
39,593
+232
| +0.6% | +$45.7K | 0.61% | 52 |
|
|
2020
Q4 | $7.17M | Buy |
39,361
+517
| +1% | +$87.9K | 0.57% | 57 |
|
|
2020
Q3 | $6.5M | Buy |
38,844
+303
| +0.8% | +$51K | 0.6% | 55 |
|
|
2020
Q2 | $6.26M | Sell |
38,541
-7,231
| -16% | -$1.3M | 0.62% | 52 |
|
|
2020
Q1 | $7.91M | Buy |
45,772
+1,134
| +3% | +$226K | 0.74% | 45 |
|
|
2019
Q4 | $8.96M | Sell |
44,638
-102
| -0.2% | -$20.9K | 0.68% | 52 |
|
|
2019
Q3 | $9.46M | Buy |
44,740
+497
| +1% | +$104K | 0.76% | 47 |
|
|
2019
Q2 | $8.59M | Buy |
44,243
+63
| +0.1% | +$11.6K | 0.71% | 50 |
|
|
2019
Q1 | $7.27M | Buy |
44,180
+123
| +0.3% | +$21.7K | 0.63% | 56 |
|
|
2018
Q4 | $8.29M | Sell |
44,057
-503
| -1% | -$92.9K | 0.8% | 47 |
|
|
2018
Q3 | $7.58M | Buy |
44,560
+788
| +2% | +$133K | 0.64% | 53 |
|
|
2018
Q2 | $7.17M | Buy |
43,772
+327
| +0.8% | +$53.4K | 0.64% | 52 |
|
|
2018
Q1 | $7.03M | Sell |
43,445
-345
| -0.8% | -$54.9K | 0.66% | 51 |
|
|
2017
Q4 | $6.4M | Buy |
43,790
+2,401
| +6% | +$342K | 0.59% | 54 |
|
|
2017
Q3 | $5.62M | Sell |
41,389
-882
| -2% | -$111K | 0.56% | 58 |
|
|
2017
Q2 | $5.29M | Buy |
42,271
+544
| +1% | +$65.1K | 0.54% | 59 |
|
|
2017
Q1 | $4.96M | Buy |
41,727
+30
| +0.1% | +$3.61K | 0.54% | 62 |
|
|
2016
Q4 | $4.81M | Sell |
41,697
-279
| -0.7% | -$31K | 0.55% | 60 |
|
|
2016
Q3 | $4.39M | Buy |
41,976
+34
| +0.1% | +$3.55K | 0.55% | 64 |
|
|
2016
Q2 | $4.09M | Buy |
41,942
+690
| +2% | +$65.2K | 0.54% | 63 |
|
|
2016
Q1 | $3.96M | Buy |
41,252
+953
| +2% | +$86.7K | 0.55% | 64 |
|
|
2015
Q4 | $3.65M | Buy |
40,299
+1,722
| +4% | +$162K | 0.52% | 67 |
|
|
2015
Q3 | $3.58M | Buy |
38,577
+3,868
| +11% | +$368K | 0.56% | 64 |
|
|
2015
Q2 | $3.23M | Buy |
34,709
+2,080
| +6% | +$194K | 0.47% | 67 |
|
|
2015
Q1 | $3.09M | Buy |
32,629
+86
| +0.3% | +$7.97K | 0.45% | 68 |
|
|
2014
Q4 | $2.88M | Sell |
32,543
-366
| -1% | -$31K | 0.42% | 73 |
|
|
2014
Q3 | $2.63M | Buy |
32,909
+1,361
| +4% | +$103K | 0.4% | 78 |
|
|
2014
Q2 | $2.24M | Buy |
31,548
+5,265
| +20% | +$371K | 0.35% | 85 |
|
|
2014
Q1 | $1.95M | Buy |
26,283
+2,407
| +10% | +$182K | 0.32% | 92 |
|
|
2013
Q4 | $1.87M | Buy |
23,876
+1,565
| +7% | +$123K | 0.31% | 92 |
|
|
2013
Q3 | $1.65M | Buy |
22,311
+474
| +2% | +$34.9K | 0.3% | 94 |
|
|
2013
Q2 | $1.66M | Buy |
+21,837
| New | +$1.43M | 0.32% | 92 |
|
Other funds holding CME
Trust Company of Vermont's CME Position: Q4 2025 in Review
Trust Company of Vermont increased its CME Group (CME) stake by 4.5% in Q4 2025, buying an estimated $769K and bringing the position to 65,905 shares worth $18M. The position accounts for 0.75% of the portfolio, ranked #38.
Trust Company of Vermont first reported a position in CME in Q2 2013 and has held it in 51 quarters since. 1,732 funds tracked by Wall St. Rank hold CME as of Q4 2025.
- Trust Company of Vermont held 65,905 shares of CME Group worth $18M as of Q4 2025.
- Trust Company of Vermont bought 2,829 CME Group shares in Q4 2025, an estimated $769K.
- CME Group made up 0.75% of Trust Company of Vermont's portfolio in Q4 2025, its #38 holding.
- Trust Company of Vermont first reported a position in CME Group in Q2 2013 and has held it in 51 quarters since.
- 1,732 funds tracked by Wall St. Rank held CME Group as of Q4 2025.
Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.